Keystone Bio is a nextgen PharmaBiome biotech that has identified and is targeting a "one of a kind Inflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.

Over 50% of individuals have it and Keystone Bio has the only biologic on the planet (PrevEvent) that eliminates it, reversing and preventing a large catalogue of our most deadly diseases